lenvatinib,sunitinib,pembrolizumab
merck,pfizer,eisai
['sunitinib', 'clear study', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva', 'pembro']
updated efficacy of lenvatinib plus
pembrolizumab versus sunitinib in
patients with mrcc in the clear study: pfs, os consistent with primary analysis! 17% cr #esmo22 
Pursuing to improve cancer prevention and care. Medical Oncologist @AnkaraUni